Clinical Trial Update: Neurobiological Drivers of Mobility Resilience: The Dopaminergic System [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial investigating dopaminergic system drivers of mobility resilience in older adults with parkinsonian signs; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinsonian Signs in Older Persons

Snippet

Sponsor: University of Michigan | Conditions: Parkinsonian Signs in Older Persons | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-28